Analyst Reco.

09/06 NOVO NORDISK : Deutsche Bank reiterates its Neutral rating ZD
09/06 NOVO NORDISK : JP Morgan sticks Neutral ZD
08/06 NOVO NORDISK : JP Morgan remains Neutral ZD
04/06 NOVO NORDISK : Goldman Sachs gives a Neutral rating ZD
03/06 Goldman Sachs raises Novo Nordisk price target to DKK 305 (263), maintains Neutral rating - BN FW
30/05 NOVO NORDISK : Jefferies remains Neutral ZD
30/05 Jefferies Examines GLP-1 Compounding, Maintains Hold Rating on Novo Nordisk Zonebourse
28/05 NOVO NORDISK : Deutsche Bank reiterates its Neutral rating ZD
21/05 Bernstein Updates Novo Nordisk Price Target, Estimates After Wegovy Pill Launch Outperforms MT
21/05 Bernstein raises price target for Novo Nordisk to DKK 200 (175), reiterates underperform - BN FW
20/05 NOVO NORDISK : Deutsche Bank sticks Neutral ZD
20/05 Intron: Novo Nordisk sales could decline in 2027 FW
19/05 NOVO NORDISK : Barclays reiterates its Neutral rating ZD
18/05 Novo Nordisk slides on signs of slowing sales momentum for Wegovy pill FW
13/05 NOVO NORDISK : Jefferies reaffirms its Neutral rating ZD
12/05 NOVO NORDISK : Bernstein keeps a Sell rating ZD
11/05 Citi raises Novo Nordisk price target following strong Wegovy pill launch FW
11/05 SB1: Market underestimates Novo Nordisk potential - raises price target FW
11/05 SB1 Markets raises Novo Nordisk price target to DKK 350 (280), reiterates Buy FW
11/05 Citigroup raises Novo Nordisk price target to DKK 290 (275), reiterates Neutral rating FW
08/05 NOVO NORDISK : Deutsche Bank gives a Neutral rating ZD
08/05 NOVO NORDISK : Gets a Neutral rating from JP Morgan ZD
08/05 NOVO NORDISK : UBS sticks Neutral ZD
08/05 NOVO NORDISK : Barclays sticks Neutral ZD
08/05 DZ Bank trims Novo Nordisk price target to DKK 299 (307), reiterates Hold - BN FW
No results match your criteria
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
BENEFIT NOW